Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/11/2020
SIETES contiene 93161 citas

 
 
 1 a 20 de 5079 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Nguyen D-D, Marchese M, Cone EB, Paciotti M, Basaria S, Bhojani N, Trinh Q-D. Investigation of suicidality and psychological adverse events in patients treated with finasteride. JAMA Dermatol 2020:11 de noviembre. [Ref.ID 103784]
2. Cita con resumen
Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M, Gabbay FJ, Davies DE, Holgate ST, Ho L-P, Clark T, Djukanovic R, Wilkinson TMA, on behalf of the Inhaled Interferon Beta COVID-19 Study Group. . The Lancet Respiratory Medicine 0:1. [Ref.ID 103778]
3.Tiene citas relacionadas Cita con resumen
Pathak EB. Convalescent plasma is ineffective for covid-19. BMJ 2020;371:22 de octubre. [Ref.ID 103776]
4. Cita con resumen
5. Cita con resumen
de Vries RD, Schmitz KS, Bovier FT, Noack D, Haagmans BL, Biswas S, Rockx B, Gellman SH, Alabi CA, de Swart RL, Moscona A, Porotto M. Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2transmissionin ferrets. biorxiv.com 2020:5 de noviembre. [Ref.ID 103772]
6.Tiene citas relacionadas Cita con resumen
Parsons L. Russia claims its COVID-19 vaccine is over 90% effective. PMLiVE 2020:1. [Ref.ID 103771]
7.Enlace a cita originalTiene citas relacionadas Cita con resumen
Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P, on behalf of the PLACID Trial Collaborators. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ 2020;371:22 de octubre. [Ref.ID 103770]
8. Cita con resumen
Gelles D. La difícil tarea de transportar una vacuna que debe estar a 80 grados Celsius bajo cero. N Y Times (Print) 2020:21 de septiembre. [Ref.ID 103767]
9. Cita con resumen
Doshi P. Covid-19 vaccine trial protocols released. BMJ 2020:m4058. [Ref.ID 103766]
10. Cita con resumen
Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet 2020:27 de octubre. [Ref.ID 103764]
11. Cita con resumen
Krause PR, Fleming TR, Ellenberg SS, Henao-Restrepo AM, on behalf of the WHO Ad Hoc Clinical Trial Expert Group. Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential. Lancet 2020:27 de octubre. [Ref.ID 103763]
12. Cita con resumen
Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ 2020;371:28 de octubre. [Ref.ID 103761]
13. Cita con resumen
Ostengaard L, Lundh A, Tjørnhøj-Thomsen T, Abdi S, Gelle MHA, Stewart LA, Boutron I, Hróbjartsson A. nfluence and management of conflicts of interest in randomised clinical trials: qualitative interview study. BMJ 2020;371:27 de octubre. [Ref.ID 103760]
14. Cita con resumen
Walsh EE, Frenck Jr RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, et al.. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med 2020:14 de octubre. [Ref.ID 103749]
15.Enlace a cita original Cita con resumen
WHO Solidarity trial consortium. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. medRxiv 2020:15 de octubre. [Ref.ID 103745]
16. Cita con resumen
Ward BJ, Makarkov A, Séguin A, Pillet S, Trépanier S, Dhaliwall J, Libman MD, Vesikari T, Landry N. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (=65 years): two multicentre, randomised phase 3 trials. Lancet 2020:13 de octubre. [Ref.ID 103743]
17. Cita con resumen
Hwang TJ, Ross JS, Vokinger KN, Kesselheim AS. Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study. BMJ 2020;371:7 de octubre. [Ref.ID 103742]
18.Enlace a cita original Cita con resumen
Kurian A, Reghunadhan I, Thilak P, Soman I, Nair U. Short-term efficacy and safety of topical ß-blockers (timolol maleate ophthalmic solution, 0.5%) in acute migraine. A tandomized crossover trial. Jama Ophthalmol 2020:1 de octubre. [Ref.ID 103736]
19. Cita con resumen
Gerhard T, Stroup TS, Correll CU, Setoguchi S, Strom BL, Huang C, Tan Z, Crystal S, Olfson M. Mortality risk of antipsychotic augmentation for adult depression. PLoS One 2020:30 de septiembre. [Ref.ID 103735]
20. Cita con resumen
Lee SW, Ha EK, Yeniova AO, Moon SY, Kim SY, Koh HY, Yang JM, Jeong SJ, Moon SJ, Cho JY, Yoo IK, Yon DK. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut 2020:30 de julio. [Ref.ID 103733]
Seleccionar todas
 
 1 a 20 de 5079 siguiente >>